Philip Sasi

1.5k total citations
36 papers, 774 citations indexed

About

Philip Sasi is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Philip Sasi has authored 36 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 12 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Philip Sasi's work include Malaria Research and Control (16 papers), Mosquito-borne diseases and control (8 papers) and HIV/AIDS drug development and treatment (8 papers). Philip Sasi is often cited by papers focused on Malaria Research and Control (16 papers), Mosquito-borne diseases and control (8 papers) and HIV/AIDS drug development and treatment (8 papers). Philip Sasi collaborates with scholars based in Tanzania, United Kingdom and Germany. Philip Sasi's co-authors include Omary Minzi, Steffen Borrmann, Sabina Mugusi, Ferdinand Mugusi, Eleni Aklillu, Kevin Marsh, Eliford Ngaimisi, Leah Mwai, Abdirahman I. Abdi and Alexis Nzila and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Philip Sasi

34 papers receiving 754 citations

Peers

Philip Sasi
Bridget Nzarubara United States
Victor Bigira United States
Denise Njama‐Meya United States
Peter B. Bloland United States
Grant Dorsey United States
Philip Sasi
Citations per year, relative to Philip Sasi Philip Sasi (= 1×) peers Podjanee Jittamala

Countries citing papers authored by Philip Sasi

Since Specialization
Citations

This map shows the geographic impact of Philip Sasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Sasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Sasi more than expected).

Fields of papers citing papers by Philip Sasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Sasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Sasi. The network helps show where Philip Sasi may publish in the future.

Co-authorship network of co-authors of Philip Sasi

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Sasi. A scholar is included among the top collaborators of Philip Sasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Sasi. Philip Sasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasi, Philip, et al.. (2024). Hypertension and immune activation in antiretroviral therapy naïve people living with human immunodeficiency virus. BMC Infectious Diseases. 24(1). 630–630. 1 indexed citations
2.
Sasi, Philip, et al.. (2024). Design, Synthesis, and In-vitro anti-tuberculosis activity of 2-substituted-1,5-diphenyl-1,2-dihydro-3H-1,2,4-triazole-3-thione Derivatives. Journal of Physics Conference Series. 2801(1). 12016–12016. 1 indexed citations
3.
Sasi, Philip, et al.. (2022). Factors influencing receipt of an antibiotic prescription among insured patients in Tanzania: a cross-sectional study. BMJ Open. 12(11). e062147–e062147. 3 indexed citations
4.
Mugusi, Sabina, Bruno Sunguya, Philip Sasi, et al.. (2021). Effect of aspirin on HIV disease progression among HIV-infected individuals initiating antiretroviral therapy: study protocol for a randomised controlled trial. BMJ Open. 11(11). e049330–e049330. 5 indexed citations
5.
Sasi, Philip. (2020). Ceftriaxone Prescription at Muhimbili National Hospital. Tanzania journal of health research. 21(2). 1–13. 3 indexed citations
6.
Kilonzi, Manase, Omary Minzi, Ritah Mutagonda, et al.. (2020). Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania. Malaria Journal. 19(1). 66–66. 3 indexed citations
8.
Ali, Ali M., Melissa A. Penny, Thomas A. Smith, et al.. (2018). Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing. Antimicrobial Agents and Chemotherapy. 62(10). 23 indexed citations
9.
Cox, Sharon E., Elizabeth A. Ellins, Charles R. Newton, et al.. (2018). Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial. The Lancet Haematology. 5(4). e147–e160. 25 indexed citations
11.
Minzi, Omary, Sabina Mugusi, Philip Sasi, et al.. (2018). Long-term efavirenz pharmacokinetics is comparable between Tanzanian HIV and HIV/Tuberculosis patients with the same CYP2B6*6 genotype. Scientific Reports. 8(1). 16316–16316. 8 indexed citations
12.
Schieck, Elise, Elizabeth J. Poole, Anja Rippert, et al.. (2017). Plasmodium falciparum variant erythrocyte surface antigens: a pilot study of antibody acquisition in recurrent natural infections. Malaria Journal. 16(1). 450–450. 3 indexed citations
13.
Makubi, Abel, Philip Sasi, Enrico M. Novelli, et al.. (2016). Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania. BMC Medical Research Methodology. 16(1). 140–140. 10 indexed citations
15.
Ngaimisi, Eliford, Omary Minzi, Sabina Mugusi, et al.. (2014). Pharmacokinetic and pharmacogenomic modelling of the CYP3A activity marker 4 -hydroxycholesterol during efavirenz treatment and efavirenz/rifampicin co-treatment. Journal of Antimicrobial Chemotherapy. 69(12). 3311–3319. 24 indexed citations
16.
Minzi, Omary, et al.. (2014). Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy. Malaria Journal. 13(1). 205–205. 24 indexed citations
18.
Mwangoka, Grace, et al.. (2009). The Ifakara Health Institute's Bagamoyo Research and Training Centre: a well-established clinical trials site in Tanzania. International Health. 1(1). 85–90. 1 indexed citations
19.
Bassat, Quique, Modest Mulenga, Halidou Tinto, et al.. (2009). Dihydroartemisinin-Piperaquine and Artemether-Lumefantrine for Treating Uncomplicated Malaria in African Children: A Randomised, Non-Inferiority Trial. PLoS ONE. 4(11). e7871–e7871. 108 indexed citations
20.
Sasi, Philip, Abdirahman I. Abdi, Leah Mwai, et al.. (2009). In Vivo and In Vitro Efficacy of Amodiaquine againstPlasmodium falciparumin an Area of Continued Use of 4‐Aminoquinolines in East Africa. The Journal of Infectious Diseases. 199(11). 1575–1582. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026